Journal Basic Info
- Impact Factor: 1.809**
- H-Index: 6
- ISSN: 2474-1655
- DOI: 10.25107/2474-1655
Major Scope
- Forensic and Legal Medicine
- Breast Neoplasms
- Veterinary Sciences
- Physical Medicine & Rehabilitation
- Hepatology
- Internal Medicine
- Pediatrics
- Endocrinology
Abstract
Citation: Ann Clin Case Rep. 2016;1(1):1124.DOI: 10.25107/2474-1655.1124
Choriocarcinoma Treated by Primary Systemic Chemotherapy and its Prevention after Hydatidiform Mole, with Methotrexate
Kazuo Maeda
Depatment of Obstetrics and Gynecology, Tottori University Medical School, Japan
*Correspondance to: Kazuo Maeda
PDF Full Text Case Report | Open Access
Abstract:
Case reports of 1) Complete remission of choriocarcinoma treated with primary systemic MTX chemotherapy achieving normal pregnancy, 2) MTX chemotherapy of choriocarcinoma brain metastases with long favorable outcome, 3) destructive mole, 4) Choriocarcinoma prevention with MTX chemotherapy after complete hydatidiform mole, and promotion of complete remission of common malignant neoplasia with various anticancer medicine without surgery.
Keywords:
Choriocarcinoma; Common malignancy; MTX; Primary chemotherapy; Complete remission; Brain metastasis; Prevention
Cite the Article:
Kazuo Maeda. Choriocarcinoma Treated by Primary Systemic Chemotherapy and its Prevention after Hydatidiform Mole, with Methotrexate. Ann Clin Case Rep. 2016; 1: 1124.
